Dr. Sise’s complete bibliography is available here.
- Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory Death
- Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records
- Identification of Immune Checkpoint Inhibitor-Induced Diabetes
- Large Discordance between Creatinine-Based and Cystatin C-Based eGFRs is Associated with Falls, Hospitalizations, and Death in Older Adults
- F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury
- Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial
- Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer
- Imaging kidney inflammation using an oxidatively activated MRI probe
- Remdesivir and Kidney and Cardiovascular Outcomes in COVID-19 Patients With Reduced GFR
- Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis
- Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer
- Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
- Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
- The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout
- Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma
- Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder Substitution
- Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline
- AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients
- Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database
- Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
